JP Patent

JP7214714B2 — 酸性ｐＨで活性の増強を示す抗真菌剤

Assigned to サイネクシス，インコーポレーテッド · Expires 2023-01-30 · 3y expired

What this patent protects

Patent listed against Brexafemme.

Drugs covered by this patent

Patent Metadata

Patent number
JP7214714B2
Jurisdiction
JP
Classification
—
Expires
2023-01-30
Drug substance claim
No
Drug product claim
No
Assignee
サイネクシス，インコーポレーテッド
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.